USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Increasing Volume and Decreasing Value
09-Jan-2014
Global
Market Research
NBAE-01-00-00-00
LS00111-GL-MR_16952
This research service analyzes merger and acquisition trends in the global pharmaceutical and biotechnology industry, along with specific merger and acquisition deals in this industry. Analysis is based on the number of and the average value of these deals. Merger and acquisition trends are also observed and analyzed based on the geographic region and buyer type. This research study delves into the nature of cross-border deals and also explores various deal multiples such as enterprise value, percent stakes sought, and target stock premium analysis of target companies. The study concludes with 5 big predictions.
Preface
- Title, Research Team, and Contents
Executive Summary
- Executive Summary and Implications
Introduction
- Introduction
The Key Rationale for M&A
- Overview
Key M&A Statistics
- Overview
Geographic Analysis
- Overview
Cross-border Deal Analysis—Buyer’s Perspective for Asia-Pacific, Europe, and North America
- Overview
Sectorial Analysis—Pharmaceutical
- Overview
Sectorial Analysis—Biotechnology
- Overview
Percent Stake Sought and Target Stock Premium Analysis
- Overview
Conclusion
- The 5 Big Conclusions
Appendix
- Additional Information
The Frost & Sullivan Story
- The Frost & Sullivan Story
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Saneesh Edacherian |
| WIP Number | NBAE-01-00-00-00 |
| Keyword 1 | pharmaceutical |
| Keyword 2 | biotechnology |
| Keyword 3 | Merger and Acquisition |
| Is Prebook | No |
Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry
$4,950.00
Special Price $3,712.50 save 25 %